Chemoinformaics analysis of 1-Benzylisoquinoline
| Molecular Weight | 219.287 | nRot | 2 |
| Heavy Atom Molecular Weight | 206.183 | nRig | 17 |
| Exact Molecular Weight | 219.105 | nRing | 3 |
| Solubility: LogS | -4.465 | nHRing | 1 |
| Solubility: LogP | 3.926 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 17 |
| nHA | 1 | APOL | 36.4883 |
| nHD | 0 | BPOL | 14.1817 |
| QED | 0.638 |
| Synth | 1.635 |
| Natural Product Likeliness | -0.307 |
| NR-PPAR-gamma | 0.651 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.092 |
| Pgp-sub | 0.207 |
| HIA | 0.007 |
| CACO-2 | -4.573 |
| MDCK | 0.0000318 |
| BBB | 0.84 |
| PPB | 0.963761 |
| VDSS | 2.041 |
| FU | 0.0290127 |
| CYP1A2-inh | 0.885 |
| CYP1A2-sub | 0.664 |
| CYP2c19-inh | 0.926 |
| CYP2c19-sub | 0.235 |
| CYP2c9-inh | 0.792 |
| CYP2c9-sub | 0.387 |
| CYP2d6-inh | 0.394 |
| CYP2d6-sub | 0.611 |
| CYP3a4-inh | 0.534 |
| CYP3a4-sub | 0.636 |
| CL | 8.731 |
| T12 | 0.454 |
| hERG | 0.108 |
| Ames | 0.746 |
| ROA | 0.059 |
| SkinSen | 0.397 |
| Carcinogencity | 0.629 |
| EI | 0.875 |
| Respiratory | 0.933 |
| NR-Aromatase | 0.048 |
| Antiviral | No |
| Prediction | 0.672353 |